Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
Cash from Operating Activities
Amphastar Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Cash from Operating Activities
$183.5m
|
CAGR 3-Years
47%
|
CAGR 5-Years
37%
|
CAGR 10-Years
19%
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Operating Activities
$22.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Operating Activities
$13.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Operating Activities
$8.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Operating Activities
$13B
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Operating Activities
$4.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
See Also
What is Amphastar Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
183.5m
USD
Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's Cash from Operating Activities amounts to 183.5m USD.
What is Amphastar Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%
Over the last year, the Cash from Operating Activities growth was 106%. The average annual Cash from Operating Activities growth rates for Amphastar Pharmaceuticals Inc have been 47% over the past three years , 37% over the past five years , and 19% over the past ten years .